SOD1P2

Across TCGA pan-cancer cohorts, SOD1P2 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of SOD1P2’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where SOD1P2 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types SOD1P2 is over-expressed in tumor, although a few such as KIRC show the opposite, repressed pattern.

COAD, LUAD, and KIRC are the cancer types where SOD1P2 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in SOD1P2 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	All	II,III,IV	+0.061	.027	2	view →
LUAD	All	All	+0.031	.025	1	view →
KIRC	Female	All	−0.028	.036	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

SOD1P2–COAD

Open the COAD breakdown →